Blog

Creative Production for Fertility & Reproductive Health

by Jason Shafton

We create work for fertility and reproductive health companies centered on authentic representation across family structures, relationship types, and journeys, rather than relying on the same recycled stock imagery every company in this category uses.

The Challenge

Stock fertility imagery is overused and limited in who it portrays

The available stock library for fertility content skews heavily toward a narrow visual archetype, married heterosexual couples, a specific age and appearance range, and gets reused across nearly every competitor's marketing, so a company relying on it looks visually identical to the rest of the category and fails to represent the LGBTQ+ couples, single parents by choice, and diverse family structures who make up a real share of the audience.

Employer-facing and patient-facing creative require different production approaches, yet often share the same process and budget

Sales collateral built to convince an HR director needs to look credible and data-forward, while patient-facing brand creative needs to build emotional trust, and treating both as one creative workstream with a shared visual language often means neither does its actual job as well as it could.

Overly sentimental creative can come across as manipulative, while strictly clinical creative can feel cold

Creative that leans hard into emotional sentimentality, soft lighting, swelling music, families reunited, can feel manufactured and manipulative to an audience that's lived the real, harder version of that journey, while creative that avoids emotion entirely to stay clinically neutral fails to build any real connection at all.

Creating real patient stories demands a level of care that most creative production processes aren't designed to provide

Using real patient stories and imagery, rather than stock talent, builds far more credibility but requires careful consent processes, sensitivity to what a patient is comfortable sharing publicly, and production practices that don't retraumatize someone recounting a difficult experience. Standard creative production workflows built for typical brand testimonials aren't designed for this level of care.

How We Help

We develop a creative approach grounded in authentic representation, including LGBTQ+ couples, single parents by choice, and diverse family structures and backgrounds, reflecting the people who actually use the product instead of defaulting to the narrow archetype found in stock libraries. It begins with intentional casting and art direction choices, rather than accepting whatever a stock search produces.

We operate distinct creative workstreams for employer-facing sales collateral and patient-facing brand content, each with a dedicated visual language: data-forward and credible for the employer track, emotionally resonant and trust-building for the patient track. This allows each to fulfill its specific purpose instead of settling for a compromised middle ground.

We intentionally balance tone between sentimentality and clinical distance, creating work that honestly recognizes the journey's real difficulty without manufacturing an emotional payoff, while communicating warmth and understanding rather than clinical detachment.

When the creative plan includes real patient stories, we establish a thoughtful consent and production process, with clear agreement about what will be shared and how, sensitive interview practices, and review rights before publication. Patients participate on their own terms, and the resulting content has the credibility only real stories can offer.

What we deliver

When every fertility company draws from the same stock photo library, they all look alike to the audience paying closest attention: patients who've realized the marketing doesn't reflect their real lives.

Our Methodology

Our creative production engagements follow a 90-day sprint. Days 1-30 shape the creative direction and casting strategy for both employer and patient workstreams and, when real patient stories are included, establish the consent and production process with appropriate care. Days 30-60 produce the first creative asset library across both tracks. Days 60-90 deliver final assets, set usage guidelines, and create a plan for ongoing creative refreshes so the library doesn't become stale or fall behind competitors. Unlike a general creative production engagement, decisions around casting, tone, and process are specifically designed to represent this audience honestly and manage real patient participation with genuine care.

The Insights You Want

Right in your inbox. We’ve done the work, and now we’re sharing it with you. Sign up to stay in the loop.

Get The Latest Updates


Enter your email address

How We Work

The first month defines the creative direction and, where applicable, starts the patient story consent process, requiring early participation from your customer success or patient relations team to find willing participants. Weeks four through eight focus on production across both employer and patient creative tracks, with review cycles making sure brand, clinical, and any patient participants are comfortable with the direction before final production.

Days 60-90 provide final assets and usage guidelines, plus a refresh plan to keep the creative library current. Most engagements take 3-4 months, or longer when real patient story production is included because of the extra care needed for scheduling and consent.

Ongoing brand and clinical review keeps the messaging accurate, while patient relations involvement is critical whenever real stories are included in the plan.

If your fertility & reproductive health company needs creative production leadership, we should talk.

Expand your marketing team output with our experts

Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.

Frequently asked questions

What is the cost of creative production for a fertility or reproductive health company?

Most engagements cost $20,000 to $45,000 for an initial asset library spanning both employer and patient creative tracks. Pricing depends on whether real patient story production is included, as the additional time and care increase the cost. Companies with an established brand identity to work from cost less than those requiring creative direction to be built from scratch.

How soon will we see results from a creative production engagement?

Creative direction and early concepts are usually complete within 30-45 days. Full asset production generally requires 60-90 days, particularly when real patient stories are included, due to the necessary consent, scheduling, and review process. After launch, improvements in engagement and brand perception are typically apparent within the next quarter as the new creative takes the place of older, more generic materials.

How will the creative production team collaborate with our current marketing and clinical staff?

We collaborate with marketing on creative direction and brand consistency, and with clinical or patient relations teams when real patient stories are included in the production plan, as they have the relationships required to identify and assist willing participants. Review cycles cover brand, clinical accuracy, and, when applicable, direct approval from every featured patient.

How does Winston Francois differ from a general creative agency?

Most creative agencies rely on available stock talent and use one shared visual language for every audience. We shape casting and creative direction around authentic representation of this audience's real diversity, while running truly distinct creative tracks for employer and patient audiences rather than producing a single compromise campaign.

How do you measure ROI for creative production work?

We compare engagement and brand recall metrics for new creative with previous campaigns. For patient-facing content specifically, we also track qualitative feedback about whether the audience feels authentically represented, a key signal in a category known for narrow, repetitive stock imagery. For employer sales collateral, we measure whether sales reports show greater credibility and engagement in deals that use the new materials.

What kind of fertility or reproductive health company is a good fit for this service?

This service is suited to companies whose existing creative depends heavily on generic stock imagery or hasn't been updated recently, as well as companies serving a genuinely diverse patient population that current marketing fails to reflect. It's particularly useful for companies with willing patient advocates who can take part in real story content, since that is typically where the greatest credibility gains occur.


Related Solutions

Solutions

Top Articles

Frank Growth – Episode 224 – The Bootstrapper’s Revenge with Alex Roy

Tuesday, June 16, 2026

Frank Growth – Episode 224 – The Bootstrapper’s Revenge with Alex Roy

Episode #224: Alex Roy — Bootstrapping an AI company for 12 years, no funding He founded an AI company in 2014—when AI was a punchline—bootstrapped it with zero outside capital, and landed Fortune 50 clients. For founders and growth operators figuring out how to build (and sell) AI products in a market that shifts every...
Frank Growth – Episode 242 – Why AI Slop Backfires with Nicole Cassese

Tuesday, October 20, 2026

Frank Growth – Episode 242 – Why AI Slop Backfires with Nicole Cassese

Episode #242: Nicole Cassese — Scaling brand voice without burning out the people behind it How to keep a brand voice consistent across 1,600+ assets and still protect the team writing them. For marketing leaders, creative directors, and copywriters running high-volume content with AI in the workflow. Nicole Cassese is the associate creative director owning...
Frank Growth – Episode 245 – The Trojan Horse Sales Strategy with Brian Gilman

Tuesday, November 10, 2026

Frank Growth – Episode 245 – The Trojan Horse Sales Strategy with Brian Gilman

Episode #245: Brian Gilman – Why the funnel breaks when you sell to the C-suite Why meetings, not MQLs, are the number that predicts pipeline on six- and seven-figure deals. For B2B marketers selling mission-critical products to chief risk and compliance officers in regulated industries. Brian Gilman is the CMO of ThetaRay, which sells cognitive...
Frank Growth – Episode 243 – Your Buyer Doesn’t Know They’re Looking with Sandra Moran

Tuesday, October 27, 2026

Frank Growth – Episode 243 – Your Buyer Doesn’t Know They’re Looking with Sandra Moran

Episode #243: Sandra Moran – Selling to a Buyer Who Doesn’t Know They’re Looking How to reposition a category when your new buyer isn’t searching for you yet. For B2B marketers moving from a legacy category to an outcome-based pitch aimed at a new economic buyer. Sandra Moran is CMO at Schoox, a learning platform...

See more

Browse Categories

See more

Ready to unlock your growth?

Book Free Call

We take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.